Page last updated: 2024-11-05

cn 100 and Arthritis, Rheumatoid

cn 100 has been researched along with Arthritis, Rheumatoid in 2 studies

CN 100: structure given in first source

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshizawa, H1
Ogawa, N1
Azuma, T2
Komatsubara, Y1

Trials

1 trial available for cn 100 and Arthritis, Rheumatoid

ArticleYear
[A long-term evaluation of CN-100 in patients with rheumatoid arthritis].
    Ryumachi. [Rheumatism], 1991, Volume: 31, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; B

1991

Other Studies

1 other study available for cn 100 and Arthritis, Rheumatoid

ArticleYear
[A clinical evaluation of CN-100 in patients with rheumatoid arthritis].
    Ryumachi. [Rheumatism], 1991, Volume: 31, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Benzothiepins; Drug Evaluation; Huma

1991